Atchinson Robert's Form 4 filing
Praxis Precision Medicines, Inc. (PRAX) · filed Oct 17, 2025
- Accession no.
- 0000902664-25-004455
- Filed
- Oct 17, 2025, 4:10 PM ET
- Trade date
- Oct 16, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 10 non-derivative transactions and 0 derivative transactions. Open-market sales total $33.2M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Atchinson RobertCIK 0001403404 | 10% Owner |
| Gross PhillipCIK 0001403413 | 10% Owner |
| Adage Capital Management, L.P.CIK 0001535978 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2025 | Common Stock, $0.0001 par value per share ("Common Stock") | SSaleAcquired | +12,600 | $90.00 | +$1,134,031.5 | 2,361,485 | Indirect | |
| Oct 16, 2025 | Common Stock | SSaleAcquired | +447 | $91.04 | +$40,694.97 | 2,361,038 | Indirect | |
| Oct 16, 2025 | Common Stock | SSaleAcquired | +1,363 | $92.03 | +$125,440.98 | 2,359,675 | Indirect | |
| Oct 16, 2025 | Common Stock | SSaleAcquired | +559 | $100.11 | +$55,961.1 | 2,359,116 | Indirect | |
| Oct 16, 2025 | Common Stock | SSaleAcquired | +27,287 | $101.00 | +$2,755,987 | 2,331,829 | Indirect | |
| Oct 16, 2025 | Common Stock | SSaleAcquired | +250,000 | $104.31 | +$26,077,375 | 2,081,829 | Indirect | |
| Oct 16, 2025 | Common Stock | SSaleAcquired | +1,661 | $130.10 | +$216,090.12 | 2,080,168 | Indirect | |
| Oct 16, 2025 | Common Stock | SSaleAcquired | +487 | $131.64 | +$64,107.95 | 2,079,681 | Indirect | |
| Oct 16, 2025 | Common Stock | SSaleAcquired | +308 | $132.19 | +$40,714.95 | 2,079,373 | Indirect | |
| Oct 16, 2025 | Common Stock | SSaleAcquired | +19,198 | $140.00 | +$2,687,720 | 2,060,175 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.